Army tests new HIV vaccine formula in early safety trial
NCT ID NCT05423418
Summary
This early-stage study tested the safety of different amounts of a vaccine booster (called ALFQ) when combined with an experimental HIV vaccine. Sixty-five healthy adults who don't have HIV received three shots over two months. Researchers compared three groups getting different booster doses to see which was safest and best at stimulating the immune system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Walter Reed Army Institute of Research, Clinical Trials Center
Silver Spring, Maryland, 20910, United States
Conditions
Explore the condition pages connected to this study.